You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 613 HER2-XPAT, a novel protease-activatable prodrug T cell engager (TCE), with potent T-cell activation and efficacy in solid tumors and large predicted safety margins in non-human primate (NHP)

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immuno-conjugates and chimeric molecules
613 HER2-XPAT, a novel protease-activatable prodrug T cell engager (TCE), with potent T-cell activation and efficacy in solid tumors and large predicted safety margins in non-human primate (NHP)

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020131010
Dec 20202908
Jan 202135010
Feb 20212008
Mar 202154010
Apr 20212603
May 20211607
Jun 2021106
Jul 2021008
Aug 2021006
Sep 2021006
Oct 202128024
Nov 202138022
Dec 202140012
Jan 20221000
Feb 20222905
Mar 20225408
Apr 20226406
May 202259012
Jun 20225008
Jul 20222005
Aug 20224104
Sep 20226609
Oct 20223303
Nov 20223806
Dec 20223504
Jan 20232404
Feb 20232000
Mar 20233209
Apr 20232808
May 20232203
Jun 20232002
Jul 20231404
Aug 20232404
Sep 20232003
Oct 20233805
Nov 20233404
Dec 20233000
Jan 2024400
Feb 20242201
Mar 20242605
Apr 20242407
May 20242403
Jun 20244303
Jul 20241502
Aug 20241102
Sep 20242206
Oct 202448015
Nov 20243007
Dec 20245806
Jan 202556011
Feb 202522014
Mar 20250011
Apr 20250011
May 2025007
Jun 2025105
Total16290372